IL17A and chronic kidney disease: The concentrations of IL-17A were elevated dramatically in patients with T2D when compared to control (p < 0.0001, Figure 5), the differences were significant for all groups with CKD (p < 0.0001, p = 0.003, and p < 0.0001 for NA-CKD, A-CKD− and A-CKD+ vs. control).